Smallpox News and Research

RSS
Smallpox is a highly contagious disease caused by the variola virus, a member of the Orthopox virus family. It is one of the most devastating diseases known to humanity, with a mortality rate as high as 30%. In 1967, the World Health Organization embarked upon an intensified vaccination campaign to eliminate smallpox, which culminated in the successful eradication of the disease globally by 1980.

By the mid-1980s, there were only two known repositories of variola virus: the Institute of Virus Preparations in Russia, and the US CDC. The events in the US in September and October 2001 highlighted the risk that the variola virus might be used as an agent of bioterrorism. Governments around the world are taking precautionary measures to be ready to deal with a potential smallpox outbreak.
Video game prepares health workers for disasters

Video game prepares health workers for disasters

Online education program improved physicians' knowledge about the diagnosis and management of diseases caused by bioterrorism

Online education program improved physicians' knowledge about the diagnosis and management of diseases caused by bioterrorism

Antibody in humans that quickly fights the smallpox virus

Antibody in humans that quickly fights the smallpox virus

Healthcare workers may be unable or unwilling to report to work during certain disasters

Healthcare workers may be unable or unwilling to report to work during certain disasters

Unexpected link between the viruses that cause feline and human AIDS

Unexpected link between the viruses that cause feline and human AIDS

Funding the "war on terror" could cost the lives of millions of Americans

Funding the "war on terror" could cost the lives of millions of Americans

HHS orders 20 million doses of smallpox vaccine from Bavarian Nordic

HHS orders 20 million doses of smallpox vaccine from Bavarian Nordic

Researchers develop new diagnostic methods to better detect future monkeypox or smallpox outbreaks

Researchers develop new diagnostic methods to better detect future monkeypox or smallpox outbreaks

Models may risk making overly optimistic predictions about the levels of public health interventions needed to bring a disease under control

Models may risk making overly optimistic predictions about the levels of public health interventions needed to bring a disease under control

U.S. stockpile of anti-flu drugs is "totally inadequate"

U.S. stockpile of anti-flu drugs is "totally inadequate"

Some strains of monkeypox are more virulent than others, depending on where in Africa the virus came from

Some strains of monkeypox are more virulent than others, depending on where in Africa the virus came from

Product claiming to protect against anthrax lacks credentials or approval

Product claiming to protect against anthrax lacks credentials or approval

Gleevec or similar drugs might be useful in preventing adverse side effects of smallpox vaccine

Gleevec or similar drugs might be useful in preventing adverse side effects of smallpox vaccine

New WHO rules mean countries could face quarantine in bid to beat killer epidemics

New WHO rules mean countries could face quarantine in bid to beat killer epidemics

New regulations to tackle disease outbreaks given the red light by the WHO

New regulations to tackle disease outbreaks given the red light by the WHO

New set of International Health Regulations to manage public health emergencies of international concern

New set of International Health Regulations to manage public health emergencies of international concern

Decision to destroy remaining stocks of the smallpox virus has again been postponed

Decision to destroy remaining stocks of the smallpox virus has again been postponed

UN wants ban on creation of smallpox virus in labs

UN wants ban on creation of smallpox virus in labs

The Gates Foundation approach to the world's health problems has its critics

The Gates Foundation approach to the world's health problems has its critics

NIAID has awarded 10 grants and 2 contracts totaling approximately $27 million to fund development of new therapeutics and vaccines against bioterrorism

NIAID has awarded 10 grants and 2 contracts totaling approximately $27 million to fund development of new therapeutics and vaccines against bioterrorism